Table 1.
Clinical information of the 343 patients with liver cancer.
| Variables | Type | Entire group (n = 343) | Testing group (n = 172) | Training group (n = 171) | p -value |
|---|---|---|---|---|---|
| Age | < =65 | 216 (62.97%) | 109 (63.74%) | 107 (62.21%) | 0.8554 |
| >65 | 127 (37.03%) | 62 (36.26%) | 65 (37.79%) | ||
| Gender | Female | 110 (32.07%) | 58 (33.92%) | 52 (30.23%) | 0.5382 |
| Male | 233 (67.93%) | 113 (66.08%) | 120 (69.77%) | ||
| Histologic grade | G1-2 | 214 (62.39%) | 106 (61.99%) | 108 (62.79%) | 1 |
| G3-4 | 124 (36.15%) | 62 (36.26%) | 62 (36.05%) | ||
| Unknown | 5 (1.46%) | 3 (1.75%) | 2 (1.16%) | ||
| AJCC stage | Stage I–II | 238 (69.39%) | 112 (65.5%) | 126 (73.26%) | 0.1695 |
| Stage III–IV | 83 (24.2%) | 47 (27.49%) | 36 (20.93%) | ||
| Unknown | 22 (6.41%) | 12 (7.02%) | 10 (5.81%) | ||
| T | T1-2 | 252 (73.47%) | 120 (70.18%) | 132 (76.74%) | 0.2386 |
| T3-4 | 88 (25.66%) | 49 (28.65%) | 39 (22.67%) | ||
| Unknown | 3 (0.87%) | 2 (1.17%) | 1 (0.58%) | ||
| M | M0 | 245 (71.43%) | 121 (70.76%) | 124 (72.09%) | 1 |
| M1 | 3 (0.87%) | 1 (0.58%) | 2 (1.16%) | ||
| Unknown | 95 (27.7%) | 49 (28.65%) | 46 (26.74%) | ||
| N | N0 | 239 (69.68%) | 118 (69.01%) | 121 (70.35%) | 1 |
| N1 | 2 (0.58%) | 1 (0.58%) | 1 (0.58%) | ||
| Unknown | 102 (29.74%) | 52 (30.41%) | 50 (29.07%) |